Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

JAMA NEUROLOGY , cilt.80, sa.8, ss.789-797, 2023 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 14
  • Captures
    • Readers: 56
  • Mentions
    • News Mentions: 38
  • Social Media
    • Shares, Likes & Comments: 2
see details

Determinants of therapeutic lag in multiple sclerosis

Multiple Sclerosis Journal , cilt.27, sa.12, ss.1838-1851, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 3
    • Policy Citations: 3
  • Captures
    • Readers: 27
  • Mentions
    • Blog Mentions: 1
see details

Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

Annals of Neurology , cilt.89, sa.6, ss.1088-1098, 2021 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 38
    • Policy Citations: 1
  • Captures
    • Readers: 76
  • Social Media
    • Shares, Likes & Comments: 31
see details

Ofatumumab versus Teriflunomide in Multiple Sclerosis

The new england journal o f medicine , ss.546-557, 2020 (SCI-Expanded)
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 403
    • Patent Family Citations: 1
    • Policy Citations: 7
  • Usage
    • Downloads: 160
    • Abstract Views: 30
  • Captures
    • Readers: 549
  • Mentions
    • Blog Mentions: 6
    • News Mentions: 243
    • References: 4
see details

Risk of secondary progressive multiple sclerosis: A longitudinal study

MULTIPLE SCLEROSIS JOURNAL , cilt.26, sa.1, ss.79-90, 2020 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 56
    • Policy Citations: 1
  • Captures
    • Readers: 156
  • Mentions
    • Blog Mentions: 1
    • News Mentions: 1
see details

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder

NEW ENGLAND JOURNAL OF MEDICINE , cilt.381, sa.7, ss.614-625, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 565
    • Policy Citations: 13
  • Captures
    • Readers: 532
  • Mentions
    • News Mentions: 30
  • Social Media
    • Shares, Likes & Comments: 218
see details

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

Muscle and Nerve , cilt.60, sa.1, ss.14-24, 2019 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 93
    • Patent Family Citations: 1
    • Policy Citations: 4
  • Usage
    • Abstract Views: 7
  • Captures
    • Readers: 242
  • Mentions
    • News Mentions: 18
  • Social Media
    • Shares, Likes & Comments: 2
see details

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , cilt.321, sa.2, ss.175-187, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 364
    • Policy Citations: 6
  • Captures
    • Readers: 505
  • Mentions
    • Blog Mentions: 4
    • News Mentions: 12
  • Social Media
    • Shares, Likes & Comments: 202
see details

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis

the new england journal of medicine , ss.1017-1027, 2018 (SCI-Expanded)
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 234
    • Policy Citations: 6
  • Captures
    • Readers: 295
  • Mentions
    • Blog Mentions: 2
    • News Mentions: 14
    • References: 4
see details

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

The Lancet , cilt.391, sa.10127, ss.1263-1273, 2018 (SCI-Expanded) identifier identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 145
    • Policy Citations: 1
    • Clinical Citations: 1
  • Captures
    • Readers: 976
  • Mentions
    • Blog Mentions: 7
    • News Mentions: 128
  • Social Media
    • Shares, Likes & Comments: 28
see details

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry , cilt.87, sa.12, ss.1343-1349, 2016 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 62
    • Policy Citations: 2
  • Captures
    • Readers: 157
  • Mentions
    • Blog Mentions: 2
    • News Mentions: 2
  • Social Media
    • Shares, Likes & Comments: 20
see details

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

the lancet , ss.1075-1084, 2016 (SCI-Expanded)
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 352
    • Policy Citations: 9
  • Captures
    • Readers: 512
  • Mentions
    • Blog Mentions: 3
    • News Mentions: 2
    • References: 2
see details

Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis

ANNALS OF NEUROLOGY , cilt.77, sa.3, ss.425-435, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 144
    • Policy Citations: 4
  • Captures
    • Readers: 180
  • Mentions
    • Blog Mentions: 2
  • Social Media
    • Shares, Likes & Comments: 3
see details

Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis

ACTA NEUROLOGICA SCANDINAVICA , cilt.115, sa.5, ss.325-330, 2007 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 43
    • Clinical Citations: 1
  • Captures
    • Readers: 34
  • Social Media
    • Shares, Likes & Comments: 600
see details

Diğer Dergilerde Yayınlanan Makaleler

Multipl Sklerozda Ölüm Nedenleri

Dicle Tıp Dergisi , cilt.49, sa.1, ss.243-248, 2022 (Hakemli Dergi) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Erken Evre Multipl Skleroz Hastalarında Yaşam Kalitesi

22.Ulusal Sinir Bilim Kongresi, Türkiye, 3 - 06 Eylül 2024

Design and Implementation of an IoT Based Mobile EEG Device using ESP8266 Microcontroller

I. INTERNATIONAL TECHNOLOGY TRANSFER SYMPOSIUM, Samsun, Türkiye, 6 - 08 Mayıs 2024

MS Hastalarında Refleksoloji ve Kegel Egzersizinin Ütiner İnkontinans Üzerin Etkisi

3. Uluslararası 5. Ulusal Tamamlayıcı Terapiler Kongresi, İzmir, Türkiye, 21 Nisan 2022

Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS

ECTRIMS 2022 26 – 28 October 2022 Amsterdam, the Netherlands 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, ss.11-14

Description of Multiple Sclerosis cohorts from the Middle East between 2009 and 2019

MS Australia Progress in MS Research Scientific Conference, Hobart, Avustralya, 4 - 05 Nisan 2022, ss.17-18 identifier

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

ECTRIMS 2022 26 – 28 October 2022 Amsterdam, the Netherlands 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, ss.967-970

MULTIPL SKLEROZ HASTALARINDA KİŞİLİK ÖZELLİKLERİNİN STİGMA, DEPRESYON VE YAŞAM KALİTESİ İLE İLİŞKİSİ

6. ULUSLARARASI HEMŞİRELİK VE İNOVASYON KONGRESİ, İstanbul, Türkiye, 22 - 23 Ekim 2022, ss.741

Artificial Intelligence Applications in Neuroscience

2. International Balkan Congress on Neurology and Neuroscience IBCNN, Tekirdağ, Türkiye, 07 Ekim 2022

Emulating randomized clinical trials in relapsing-remitting multiple sclerosis with nonrandomized real-world evidence: an application using data from the MSBase registry

ECTRIMS 2022 26 – 28 October 2022 Amsterdam, the Netherlands 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, ss.379-380

Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi -National Registry

Annual Meeting of the American-Academy-of-Neurology, Washington, Amerika Birleşik Devletleri, 2 - 07 Nisan 2022 identifier

Multiple Skleroz Hastalarında Geniş Band Timpanometri Bulguları

9. Ulusal Otoloji Nörootoloji Kongresi-11. Koklear İmplant ve Odyoloji Kongresi, Türkiye, 10 Mart 2022

Biopsychosocial Evaluation in A Case with Multipl Sclerosis Accompanied by Lower Urinary Tract Dysfunctions

3rd World Congress on Primary Healthcare and Medicare Summit, 2022, Samsun, Türkiye, 07 Şubat 2022

Multipl Skleroz ve Mikrobiyota

8. Ulusal Bağırsak Mikrobiyotası ve Probiyotik Kongresi, Antalya, Türkiye, 11 - 14 Eylül 2021

Effect of self-acupressure on fatigue among patients with multiple sclerosis

37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 13 - 15 Ekim 2021, cilt.27, ss.737

Artificial Intelligence Based Gait Analysis in Multiple Sclerosis Patients

1st International Balkan Congress on Neurology and Neuroscience, Türkiye, 3 - 04 Eylül 2021

Tıpta dijitalleşme ve yapay zeka

Azerbeycan Tıpta Güncel Sorunlar Kongresi, Azerbaycan, 08 Ekim 2021

Sinir Bilim ve Yapay Zeka

6. İlaç ve Tedavi Kongresi-Akıllı İlaç Kullanımı, Türkiye, 22 - 26 Eylül 2021

Sanal Nörorehabilitasyon Uygulamasının Multipl Skleroz Hastalarının Yaşam Kalitesine ve Hastalık Seyrine Etkisi

Eskişehir Nöroloji Günleri Nöro-Romatoloji Sempozyumu Multipl Skleroz ve Ayrıcı Tanıda Romatolojik Hastalıklar, Türkiye, 3 - 05 Eylül 2021

Multıple Skleroz Hastalarında Kontralateral Supresyon

8. Ulusal Otoloji Nörotoloji Kongresi, online, Türkiye, 26 Haziran 2021

Multipl Skleroz (MS) Tanılı Bireylerin Öznel İyi Oluş Durumlarının İncelenmesi

I. Lisansüstü Hemşirelik Araştırmaları Sempozyumu, Samsun, Türkiye, 26 Kasım 2020

Davetli Konuşmacı

56.Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım 2020

Bilimsel Sekreterya

11.Klinik Nöroimmunoloji Sempozyumu, Türkiye, 19 Kasım 2020

Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020

Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis (2002)

American Academy of Neurology, Amerika Birleşik Devletleri, 14 - 26 Nisan 2020, cilt.94, ss.2002

Determinants of Therapeutic Lag in Multiple Sclerosis (2059)

American Academy of Neurology, Amerika Birleşik Devletleri, 14 - 27 Nisan 2020, cilt.94, ss.2059

Identification of Therapeutic Lag in Multiple Sclerosis

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Şubat - 01 Mart 2020

Identification of Therapeutic Lag in Multiple Sclerosis (1787)

American Academy of Neurology, Amerika Birleşik Devletleri, 14 - 19 Nisan 2020, cilt.94, ss.1787

Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94 identifier

Impact Of Eculizumab On Quality Of Life In AQP4NMOSD: Findings From The PREVENT Study

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020

Caregiver Burden in MS

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020

Long-term Safety And Effectiveness Of Eculizumab In Neuromyelitis Optica Spectrum Disorder

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020, ss.107

Does Obesity Affect Clinical Course in Patients with Multiple Sclerosis?

2. Uluslararası Sağlıklı Beslenme Kongresi, Ankara, Türkiye, 10 - 12 Ekim 2019

MULTİPL SKLEROZ HASTALARINDA OBEZİTE KLİNİK SEYRİ ETKİLER Mİ?

2. Uluslararası Sağlıklı Beslenme Kongresi, Ankara, Türkiye, 10 - 12 Ekim 2019

Olgu örnekleri ile MS, NMO, ADEM ve demyelinizan hastalıklar spektrumunda BOS incelemesi

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019

Gebelik ve İmmün Kökenli Nörolojik Hastalıklar:Planlama-İzlem ve Tedavi

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019

EP - 12 PARKİNSON HASTALIĞINDA SUBKUTANAPOMORFİN DENEYİMİ

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019, ss.122

Panel Tartışması

MS Days VI, İstanbul, Türkiye, 31 Ekim - 02 Kasım 2019

Effect of kinesiophobia on functional level and quality of life inmultiple sclerosis

XXIV WORLD CONGRESS OF NEUROLOGY - WCN 2019, Dubai, Birleşik Arap Emirlikleri, 27 - 31 Ekim 2019

Does obesıty affect clınıcal course in patients with multiple sclerosis

2. ULUSLARARASI sAĞLIKLI BESLENME KONGRESİ, Ankara, Türkiye, 10 - 12 Ekim 2019, ss.391-402

OTURUM BAŞKANI

4. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Kütahya, Türkiye, 4 - 05 Ekim 2019

SEMPOZYUM DÜZENLEME KURULU

Multipl Skleroz Hasta Bakım Sempozyumu, Mardin, Türkiye, 20 - 22 Eylül 2019

OTURUM BAŞKANI-25 Adım Yürüme Testi, 9 Delikli Test, PASAT Testi Eğitimi ve Sertifikasyon

Multipl Skleroz Hasta Bakım Sempozyumu, Mardin, Türkiye, 20 - 22 Eylül 2019

Long-term safety and effectiveness of eculizumab in neuromyelitis optica spectrum disorder

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Therapeutic lag in relapsing multiple sclerosis

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

MS cohorts and treatment utilization in academic centres in the Middle East

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Multiple Sclerosis Severity Score (MSSS) helps predict relapses and recovery from disability in patients treated for multiple sclerosis in the MSBase model

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Aggressive form of multiple sclerosis can be predicted early after disease onset

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Modifiers of the effectiveness of MS immunotherapies

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Determinants of therapeutic lag in relapsing multiple sclerosis

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Real-world experience with Ocrelizumab in the MSBase Registry

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019

Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.751 identifier

Impact of eculizumab on hospitalization rates and relapse treatment in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.288-289 identifier

Impact of eculizumab on reported quality of life in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the PREVENT study

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.294-295 identifier

Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.870 identifier

Personalizing treatment effect based on patient's baseline profile: a statistical modelling approach applied to randomized clinical trial and observational study data

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.788-790 identifier

Subgroup analyses from the Phase 3 PREVENT study in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.289-290 identifier

A multicenter international study to evaluate different aspects of relationship between MS and pregnancy

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.176-177 identifier

Impact of eculizumab on disability measures in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: phase 3 PREVENT study

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.737-738 identifier

Multipl Skleroz Epidemiyolojisi, Genetik ve Çevresel Risk Faktörleri

1. Multipl Skleroz ve Otoimmun Hastalıklarda Çocukluktan Erişkinliğe Geçiş Sempozyumu, Kütahya, Türkiye, 14 - 16 Haziran 2019

OTURUM BAŞKANI - Erken MS Rehabilitasyonu: Gözden Kaçan Bir Fırsat Penceresi mi ?

MS’xxDE SAĞLIKLI YAŞAM SEMPOZYUMU, İzmir, Türkiye, 25 - 26 Mayıs 2019

Clinical determinants and therapeutic modifiers of relapse and disability outcomes in neuromyelitis optica spectrum disorder

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019

Nöroimmunolojik hastalıklarda laboratuvardan kliniğe

III. Klinik Nöroimmünoloji Akademisi, Trabzon, Türkiye, 20 - 21 Nisan 2019

MODERATÖR

III. Klinik Nöroimmünoloji Akademisi, Trabzon, Türkiye, 20 - 21 Nisan 2019

Tedaviyi Sonlandırmak Mümkün mü?

8. TEMEL İMMUNOLOJİ VE NÖROİMMUNOLOJİ OKULU 2019, Muğla, Türkiye, 4 - 07 Nisan 2019

OTURUM BAŞKANI :Nöroimmunolojik Testleri Tanımak ve Anlamak – Laboratuvardan Kliniğe

8. TEMEL İMMUNOLOJİ VE NÖROİMMUNOLOJİ OKULU 2019, Muğla, Türkiye, 4 - 07 Nisan 2019

MOG’la İlişikili Demiyelinizan Hastalıklar

14. Uludağ Nöroloji Günleri, Bursa, Türkiye, 10 - 13 Mart 2019

P148 - Familial Involvement in Multiple Sclerosis

Americas Committee for Treatment and Research in Multiple Sclerosis 2019, DALLAS, Amerika Birleşik Devletleri, 28 Şubat - 02 Mart 2019

DÜZENLEME VE BİLİMSEL KURUL

International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019

OTURUM BAŞKANI - MULTİPL SKLEROZ’DA LABROTUVAR

International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019

Multipl Skleroz’da BOS

International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019

NÖROLOJİDE MESLEK HASTALIKLARI VE ÇEVRE SAĞLIĞI ÇALIŞTAYI- Çevresel Faktörler ve Multipl Skleroz

54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018

MS, NMO, ADEM ve Demiyelinizan Hastalıklar Spektrumunda BOS İncelemesi

54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018

MULTİPL SKLEROZ AİLE ÖYKÜSÜ OLAN HASTALARIN KLİNİK VE DEMOGRAFİK ÖZELLİKLERİ

54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, ss.315

KARDEŞ SIRASININ MULTİPL SKLEROZ TANISIYLA İLİŞKİSİ

54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, ss.315

MULTİPL SKLEROZ’DA FİNGOLİMOD TEDAVİSİNİN BEŞİNCİ YIL ETKİNLİK VE GÜVENİLİRLİK VERİLERİ

54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, ss.64

MS’TE SEMPTOMATİK TEDAVİLER

3. MULTİPL SKLEROZDA KOGNİSYON SEMPOZYUMU, İzmir, Türkiye, 10 - 11 Kasım 2018

Nöroimmünoloji Laboratuarı

13. ÇUKUROVA NÖROLOJİ GÜNLERİ, Gaziantep, Türkiye, 19 - 21 Ekim 2018

Olgularla İnflamatuar SSS ve PSS Hastalıklarında Tanı ve Tedavi Gecesi

13. ÇUKUROVA NÖROLOJİ GÜNLERİ, Gaziantep, Türkiye, 19 - 21 Ekim 2018

RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the ’xxRELOMS-T’xx

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.100

Familial multiple sclerosis: comparing demographic and clinical characteristics with sporadic form

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.31

Early clinical predictors of severe MS

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.164

Methylprednisolone concentration in milk and serum during and shortly after IV pulse therapy in patients with MS

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.251

Determinants of MS re-activation after discontinuing therapies

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.122

Disability outcomes in patients with early cerebellar symptoms in multiple sclerosis

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.93

Determinants of disability accumulation in secondary-progressive multiple sclerosis

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.30

Clinical and therapeutic predictors of relapse and disability outcomes in neuromyelitis optica spectrum disorder

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.164

SEMPOZYUM BİLİMSEL KURULU

MS MASTER 2018, Nevşehir, Türkiye, 28 - 30 Eylül 2018

Demiyelinizan Hastalıklarda Ayırıcı Tanı

MS MASTER 2018, Nevşehir, Türkiye, 28 - 30 Eylül 2018

Yeni Ufuklar – Bunun “medium”u var mı? Engelliğin Ölçümünde Giyilebilir TeknolojilerOturum Başkanları: Dr. Murat Terzi

2. Multipl Sklerozda Fiziksel Engelliliğin Ölçümü Sempozyumu, İzmir, Türkiye, 19 - 20 Mayıs 2018

X. Oturum: MS’de Nörorehabilitasyon Çalışma Gruplarının Oluşturulması- Oturum Başkanı

3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018

KOORDİNATÖR

3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018

V.Oturum: Nörorehabilitasyonda Müzik Terapi- Oturum Başkanı

3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018

KONUŞMACI.

10. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 1 - 05 Nisan 2018

Multipl Sklerozda Veri Girişinde Karşılaşılan Sorunlar

Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018

Oturum Başkanı

Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018

Örnek Veri Tabanlarına Hasta Girişi Pratiği

Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018

DÜZENLEME KURULU

Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018

Mortality in Multiple Sclerosis

10th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Ho Chi Minh City, Vietnam, 23 - 25 Kasım 2017, cilt.24, ss.383 identifier

Vitamin D Receptor Gene Polymorphism in Patients with Multiple Sclerozis

Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), 24 - 26 Şubat 2018, cilt.24, ss.117-118

Vitamin D Receptor Gene Polymorphism in Patients with Multiple Sclerosis

Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), California, Amerika Birleşik Devletleri, 1 - 03 Şubat 2018, cilt.24, ss.61-62 identifier

Tumor Necrosis Factor Alpha and Beta Receptor Gene Polymorphism in Multiple Sclerosis Patients

Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), California, Amerika Birleşik Devletleri, 1 - 03 Şubat 2018, cilt.24, ss.62 identifier

FİNGOLİMOD KULLANIMI SIRASINDA GELİŞEN DERİN VEN TROMBOZU

53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017

MULTIPL SKLEROZ’DA MORTALİTE

53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017

Klinik İzole Sendromda Cladribine Deneyimi

53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017

MULTİPL SKLEROZ’DA NATALİZUMAB TEDAVİSİ GERÇEK YAŞAM VERİSİ

53. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.229-230

De Novo Trigeminal Neuralgia Induced by Dalfampridine (4-aminopyridine): 3 cases

Pan-Asian Committee for treatment snd research in multiple sclerosis, 23 - 25 Kasım 2017

VARIABLES THAT AFFECT LİFE SATISFACTİON OF MULTİPLE SCLEROSİS PATİENTS A COMPARATİVE STUDY

Pan-Asian Committee on Treatment and Research in Multiple Sclerosis (PACTRIMS)., 22 - 25 Kasım 2017

Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)Location: Paris, FRANCEDate: OCT 25-28, 2017, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.71-73

A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: patients switching within firstline agents or to natalizumab or fingolimod in active RRMS

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)Location: Paris, FRANCEDate: OCT 25-28, 2017, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.395-397

Methylprednisolone concentrations in breast milk and serum in patients with multiple sclerosis treated with IV pulse methylprednisolone

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.462 identifier

Susac syndrome: clinical features, laboratory testing and treatment responses of 20 cases

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.90-91 identifier

Relation of fingolimod treatment to disability in multiple sclerosis

23rd World Congress of Neurology (WCN), Kyoto, Japonya, 16 - 21 Eylül 2017, cilt.381, ss.1058 identifier

Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.327-328 identifier

Familial involvement in multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.775 identifier

Frequency of cognitive impairment in relapsing-remitting multiple sclerosis patients in Turkey and affecting factors

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.458-459 identifier

Multiple Sclerosis Injection in The Form of Use Disease Modifying Drugs, Why is The End?

9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.332-333 identifier

TÜRKİYE DE FİNGOLİMOD İLE İLGİLİ GERÇEK YAŞAM DENEYİMLERİNDE ETKİNLİK

52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016

MULTİPL SKLEROZDA PROGNOZDA BOS UN ÖNEMİ

52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016

Nöromiyelitis Optica ve Gebelik

52.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016

S 80 Multipl Sklerozda Fingolimod Tedavisinin Özürlülük ile İlişkisi

52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016, ss.51

BP 63 Nöromiyelitis Optika ve Gebelik

52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016

Nöromiyelitis Optika ve Gebelik

52. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016

İKİNCİ BASAMAK TEDAVİ KARARINDA DİKKAT EDİLECEK NOKTALAR NELERDİR

52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016

BP 59 Susac Sendromlu 19 Olgu

52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016

TEP 140 Nöromiyelitis Optika ve Gebelik

52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016

SUSAC SENDROMLU 19 OLGU

52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016, ss.107

Değiştirilemez gerçekte anlam bulmak

52. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2016, cilt.27, ss.173

Multıple Sclerosıs Injectıon in The Form of Use Disease Modifying Drugs Why is The End

9th Pan Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), 27 - 29 Ekim 2016

OLGU EŞLİĞİNDE MS HASTASINA YAKLAŞIM

11. ÇUKUROVA NÖROLOJİ GÜNLERİ, Türkiye, 30 Eylül - 02 Ekim 2016

Individual response to disease modifying therapies a global observational cohort study

32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016

Outcomes of pregnancy in neuromyelitis optica patients:turkish multicenter study data

ECTRIMS 2016 - 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis., Londrina, Brezilya, 14 - 17 Eylül 2016

Efficacy and the safety profile of fingolimod treatment in multiple sclerosis patients: Real-life data from Turkey

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis. ECTRİMS-2016, Londrina, Brezilya, 14 - 17 Eylül 2016

Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey

ECTRIMS 2016 - 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis., Londrina, Brezilya, 14 - 17 Eylül 2016

MS TE YORGUNLUĞUN DEĞERLENDİRİLMESİ

IX. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 2 - 04 Haziran 2016

NÖRODEJENERASYON

IX. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 2 - 04 Haziran 2016

OTURUM BASKANI

VI. TEMEL İMMÜNOLOJİ VE NÖROİMMÜNOLOJİ ÖĞRENCİ OKULU, Türkiye, 8 - 09 Nisan 2016

GBS

VI. TEMEL İMMÜNOLOJİ VE NÖROİMMÜNOLOJİ ÖĞRENCİ OKULU, Türkiye, 8 - 09 Nisan 2016

Demyelinating diseases of the central nervous system

2nd Neuroscience Stereology and Scientific Writing, 15 - 19 Mart 2016

MS TEDAVİSİNDE GEÇİŞLERİ NE ZAMAN YAPALIM

11. ULUDAĞ NÖROLOJİ GÜNLERİ, Türkiye, 10 - 13 Mart 2016

Ailevi multipl skleroz

51. ulusal nöroloji kongresi konuşma, Türkiye, 28 Kasım - 03 Aralık 2015

Nörolojik Hastalıklarda plazmaferez ve IVIG

51. ulusal nöroloji kongresi konuşma, Türkiye, 28 Kasım - 03 Aralık 2015

fingolimod tedavisinin güvenilirliği

51. ULUSAL nöroloji kongresi, Türkiye, 28 Kasım - 02 Aralık 2015

NMO KLİNİĞİ İLE PREZENTE OLAN SJÖGREN SENDROMU

51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015

Efficacy and Treatment Persistence of First line Natalizumab vs Interferon beta or Glatiramer Acetate in relapsing MS

8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), 19 - 21 Kasım 2015

Nöromiyelitis optika klinik ve tedavisi

10. çukurova nöroloji günleri, Türkiye, 13 - 15 Kasım 2015

Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 21 - 22 Ekim 2015

10 year progression predictors after first treatment initiation in a relapsing remitting MS cohort

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 21 - 23 Ekim 2015

Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, cilt.21, ss.308-310 identifier

Defining secondary progressive multiple sclerosis

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, cilt.21, ss.798-800 identifier

TİP II ODONTOİD KIRIĞINA KLİNİK VE CERRAHİ YAKLAŞIM

Türk Nöroşirürji Derneği, 29. Bilimsel Kongresi, Türkiye, 17 - 21 Nisan 2015

MALİGN İSKEMİK İNME SONRASINDA DEKOMPRESİF CERRAHİ

Türk Nöroşirürji Derneği, 29. Bilimsel Kongresi, Türkiye, 17 - 21 Nisan 2015

Panelist

OMÜ Tıp Fakültesi Dekanlığı 'Kaliteli uyuyor muyum?' paneli, Türkiye, 04 Haziran 2014

Stereological and comparative evaluation of the carpal tunnel in patients with carpal tunnel syndrome using magnetic resonance images

3. International Scientific Writing&Stereology Workshop, Ondokuz Mayıs University, 08-12 Nisan 2014 Samsun, Turkey, 8 - 12 Nisan 2014, cilt.31

Nöromiyelitis Optika ve Nöromiyelitis Optika Spektrumu

8. Klinik Nöroimmünoloji Sempozyumu, Türkiye, 3 - 06 Nisan 2014

KLİNİSYEN GÖZÜYLE NMO’NUN EVRİMİ

8. Klinik Nöroimmünoloji Sempozyumu, Türkiye, 3 - 06 Nisan 2014

Multiple skleroz hastasında trigeminal-glossofaringeal nevralji birlikteliği

Türk Nöroşirürji Derneği 27. Bilimsel Kongresi, Antalya, Türkiye, 12 - 16 Nisan 2013

Clinical And Radiological Characteristics Of Tumefactive Demyelinating Lesions: Follow-up Study

5th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Beijing, Çin, 13 - 15 Eylül 2012, cilt.19, ss.656 identifier

NMO-spectrum disorders in Turkish population: Clinical, demographic characteristics and the presence of NMO-Ig G

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.27 identifier

Targetin thalamic tremor cells in deep brain stimulation for multiple sclerosis induced complex tremor’

20. Congress of the European Society for Stereotactic and Functional Neurosurgery, 26 - 28 Eylül 2012

Tumefactive multiple sclerosis lesions: demographic, clinical, radiological characteristics

26rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 10 - 12 Ekim 2010

Eye-of-tiger sign in multiple sclerosis: a case report

14th Congress of the European Federation of Neurological Societies, 26 - 28 Eylül 2010

Tedaviye Dirençli Epileptik Nöbetleri Olan Multipl Skleroz Olgusu

Tedaviye Dirençli Epileptik Nöbetleri Olan Multipl Skleroz Olgusu, Türkiye, 10 - 15 Ekim 2009

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009, ss.200

Any realtion between multiple sclerosis and bone metabolism?

25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009, ss.166

Evoked potentials in multiple sclerosis

25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009

Multiple sclerosis and vitamin B12 metabolism

25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009

Factors associated with osteoporosis in patients with multiple sclerosis

5th World Congress of the International Society of Physical and Rehabilitation Medicine, 13 - 17 Haziran 2009

Mononöritis Multipleks Kliniği ile Prezante Olan Sjögren Sendromu: Olgu Sunumu

Mononöritis Multipleks Kliniği ile Prezante Olan Sjögren Sendromu: Olgu Sunumu, Türkiye, 11 - 16 Ekim 2008

Tumefactive demyelinating disease is immunologically different from multiple sclerosis

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 11 - 14 Ekim 2007

The relationship between multiple sclerosis and other autoimmune diseases

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 11 - 14 Ekim 2007

Subakut Kombine Dejenerasyon Tanısı Alan 9 Olgunun Klinik ve Demografik Özellikleri

Subakut Kombine Dejenerasyon Tanısı Alan 9 Olgunun Klinik ve Demografik Özellikleri, Türkiye, 10 - 15 Ekim 2007

Periferal Nöropati ile Prezante Olan Anti Yo (+) Over Karsinomu: Olgu Sunumu

Periferal Nöropati ile Prezante Olan Anti Yo (+) Over Karsinomu: Olgu Sunumu, Türkiye, 10 - 15 Ekim 2007

Nörobehçette Klinik, Radyolojik ve Demografik Özellikler

Nörobehçette Klinik, Radyolojik ve Demografik Özellikler, Türkiye, 10 - 15 Ekim 2007

Evaluation Of Multıple Sclerosis Lesions With Diffusion Weighted Imaging

Esnr 06 European Socıety Of Neuroradıology 31.Th Congress Advanced Courses, 13 - 16 Eylül 2006

A comparative study of evoked potentials and EMG in Turkish patients with Multiple sclerosis and Neurobehçet’s syndrome

A comparative study of evoked potentials and EMG in Turkish patients with Multiple sclerosis and Neurobehçet’s syndrome, Türkiye, 2 - 07 Temmuz 2006

Kluver-Bucy Sendromu

TMRD TÜRK MANYETİK REZONANS DERNEĞİ IX. Ulusal Manyetik Rezonans Derneği, Türkiye, 25 - 27 Mayıs 2006

CSF total tau Protein Level and it Relation with Diffusion MRI in Multiple Sclerosis Patients

21rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 28 Eylül - 01 Ekim 2005

Cognitive impairment in fibromyalgia patients without depression

Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.346 identifier

Kitap & Kitap Bölümleri

Her Yönüyle Kenevir

Ondokuz Mayıs Üniversitesi, Samsun, 2023

Yaşlılık ve Deliryum

Geriatrik Psikiyatri, KABATAŞ YILDIZ Mükerrem, Editör, Nobel Akademik Yayıncılık, Ankara, ss.99-120, 2022

Multipl Sklerozda Tanı Yöntemleri Beyin Omurilik Sıvısı

Multipl Skleroz, Yeşim Beckmann, Cihat Uzunköprü, Editör, Ema Tıp Kitap Evi, Samsun, ss.179-192, 2021

MULTİPL SKLEROZ VE BESLENME

MULTİPL SKLEROZ, YEŞİM BECKMAN CİHAT UZUNKÖPRÜ, Editör, EMA TIP KİTAPEVİ, İstanbul, ss.537-549, 2021

Multipl Skleroz Tedavi Geçişlerinde Uygulamalar

Türkiye Klinikleri Nöroloji Özel Konular-Multipl Skleroz, Taşkın Duman, Editör, Türkiye Klinikleri, ss.88-93, 2020

Soru ve Yanıtlarla Multipl Skleroz

No-bel Matbaacılık San.Tic.Ltd. Şti., 2018

Metrikler

Yayın

598

Atıf (WoS)

1591

H-İndeks (WoS)

25

Atıf (Scopus)

3509

H-İndeks (Scopus)

28

Atıf (TrDizin)

8

H-İndeks (TrDizin)

2

Proje

45

Tez Danışmanlığı

20

Açık Erişim

47
BM Sürdürülebilir Kalkınma Amaçları